Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers
摘要:
Novel cyclopentane-based 3-phenyl-1-hydroxypropyl compounds were evaluated for inhibitory activity against the peripheral nerve sodium channel Na(v)1.7 and off-target activity against the cardiac potassium channel hERG. The stereochemistry of the hydroxyl group and substitution on the phenyl rings with either fluorinated O-alkyl or alkyl groups were found to be critical, for conferring potency against Na(v)1.7. A benchmark compound from this series displayed efficacy in rat models of inflammatory and neuropathic pain. (C) 2005 Elsevier Ltd. All rights reserved.
Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers
摘要:
Novel cyclopentane-based 3-phenyl-1-hydroxypropyl compounds were evaluated for inhibitory activity against the peripheral nerve sodium channel Na(v)1.7 and off-target activity against the cardiac potassium channel hERG. The stereochemistry of the hydroxyl group and substitution on the phenyl rings with either fluorinated O-alkyl or alkyl groups were found to be critical, for conferring potency against Na(v)1.7. A benchmark compound from this series displayed efficacy in rat models of inflammatory and neuropathic pain. (C) 2005 Elsevier Ltd. All rights reserved.
Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers
作者:Dong Ok、Chunshi Li、Catherine Abbadie、John P. Felix、Michael H. Fisher、Maria L. Garcia、Gregory J. Kaczorowski、Kathryn A. Lyons、William J. Martin、Birgit T. Priest、McHardy M. Smith、Brande S. Williams、Matthew J. Wyvratt、William H. Parsons
DOI:10.1016/j.bmcl.2005.11.051
日期:2006.3
Novel cyclopentane-based 3-phenyl-1-hydroxypropyl compounds were evaluated for inhibitory activity against the peripheral nerve sodium channel Na(v)1.7 and off-target activity against the cardiac potassium channel hERG. The stereochemistry of the hydroxyl group and substitution on the phenyl rings with either fluorinated O-alkyl or alkyl groups were found to be critical, for conferring potency against Na(v)1.7. A benchmark compound from this series displayed efficacy in rat models of inflammatory and neuropathic pain. (C) 2005 Elsevier Ltd. All rights reserved.